机械化学消融与热消融治疗大隐静脉功能不全的随机试验:七年随访
本研究报道了机械化学消融(MOCA)与热消融(TA)治疗大隐静脉(GSV)功能不全的7年耐久性结果。125例患者随机接受MOCA、EVLA或RFA,7年随访时89例(71.2%)完成。在GSV近端(上20cm),MOCA组反流率23%(10/44)高于TA组7%(3/42)(p=.032)。结论:MOCA与TA相比,更常出现静脉再通、反流复发和额外治疗。
要点
- MOCA治疗GSV功能不全7年后近端反流率显著高于TA(23% vs 7%,p=.032)。
- MOCA组在3至7年间有2例再手术,TA组无再手术。
- 两组间AVVQ测量的疾病特异性生活质量无差异。
核心结论
- 治疗GSV功能不全7年后,MOCA较TA更常与静脉再通、反流复发和额外治疗相关。
研究设计与样本
- 随机对照试验,2014-2015年在赫尔辛基大学医院招募患者,按2:1:1随机分配至MOCA、EVLA和RFA。
- 共125例接受分配治疗,7年随访时89例(71.2%)参与。
- 主要结局为GSV在1个月、1年、3年及7年时的通畅率和反流(因COVID-19疫情,原定5年改为7年)。
主要发现
- 在治疗GSV近端(上20cm),MOCA组44例中10例(23%)检测到反流,TA组42例中3例(7%)检测到反流(p=.032)。
- 3至7年随访间,MOCA组2例对既往治疗GSV段再手术,TA组无再手术。
- MOCA与TA之间AVVQ测量的生活质量无差异。
临床怎么用
- 对于GSV功能不全,TA在7年耐久性方面可能优于MOCA,表现为更低的近端反流率和再干预需求。
- 临床选择消融方式时,需权衡MOCA较高的远期反流和再治疗风险与TA的其他因素。
局限性
- 7年随访仅71.2%患者参与,存在失访偏倚可能。
- 随访时间因COVID-19疫情由预设5年改为7年。
- 样本量有限,仅125例接受治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment of superficial venous insufficiency has been associated with high rates of recurrent symptoms and or recurrent varicose veins; therefore, there is a need for new treatment options associated with long lasting outcomes. This study reports the 7 year durability of mechanochemical ablation (MOCA) and thermal ablation (TA) for treating great saphenous vein (GSV) insufficiency in patients with Clinical Etiological Anatomical Pathophysiological (CEAP) class 2 - 4 (C2 - C4) venous insufficiency in the GSV in a single leg. METHODS: After recruitment in 2014 - 2015 at Helsinki University Hospital, patients were randomised 2 : 1 : 1 for MOCA, EVLA, and RFA. The GSV was evaluated with a duplex Doppler ultrasound examination, and disease specific quality of life (QoL) was assessed with the Aberdeen Varicose Vein Questionnaire (AVVQ). The primary outcome measures were patency and reflux of the GSV at 1 month, 1 year, and 3 years, and, instead of the pre-specified 5 years, at 7 years due to the COVID-19 pandemic. The secondary outcome was the need for further interventions in the treated GSV. RESULTS: Originally, 125 patients received the allocated treatment. The seven year follow up visits were attended by 89 of 125 (71.2%) patients. In the proximal part of the treated GSV (upper 20 cm), reflux was detected in 10 of 44 (23%) and three of 42 (7%) patients in the MOCA and TA groups (p = .032). Between the three and seven year follow up visits, two patients in the MOCA group had re-operations on the previously treated GSV segment, while no re-operations were required in the TA group. No QoL differences as measured by the AVVQ were shown between MOCA and TA. CONCLUSION: Seven years after the treatment of GSV insufficiency, MOCA is more often associated with vein recanalisation, recurrent reflux, and additional treatments than TA.
引用
- Hurmerinta-Kurkijärvi OLL, Weselius EJ, Vähäaho SM, et al. Randomised Trial of Mechanochemical or Thermal Ablation for Great Saphenous Vein Insufficiency: Seven Year Follow Up. Eur J Vasc Endovasc Surg. 2026. PMID: 42401285. doi:10.1016/j.ejvs.2026.06.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。